Grail (NASDAQ:GRAL) Stock Price Down 4.1% – Time to Sell?

Shares of Grail, Inc. (NASDAQ:GRAL) were down 4.1% during trading on Wednesday . The stock traded as low as $39.00 and last traded at $39.82. Approximately 1,246,067 shares traded hands during mid-day trading, an increase of 4% from the average daily volume of 1,201,935 shares. The stock had previously closed at $41.54.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Morgan Stanley started coverage on shares of Grail in a research note on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price target for the company. Wolfe Research started coverage on Grail in a research note on Friday, November 15th. They set a “peer perform” rating for the company.

Grail Stock Down 1.7 %

The company’s fifty day moving average is $30.38 and its two-hundred day moving average is $20.69.

Grail (NASDAQ:GRAL) last announced its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating analysts’ consensus estimates of ($4.41) by $2.55. The firm had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. Equities analysts forecast that Grail, Inc. will post -15.15 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new position in shares of Grail during the fourth quarter worth about $244,000. Moloney Securities Asset Management LLC purchased a new position in Grail during the 4th quarter worth $559,000. Wesbanco Bank Inc. acquired a new stake in shares of Grail in the 4th quarter worth $523,000. Slow Capital Inc. purchased a new stake in shares of Grail in the fourth quarter valued at about $2,379,000. Finally, abrdn plc acquired a new position in shares of Grail during the fourth quarter worth about $3,768,000.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.